Pinebridge Investments L.P. Grows Position in Cooper Companies Inc (NYSE:COO)
Pinebridge Investments L.P. lifted its position in Cooper Companies Inc (NYSE:COO) by 221.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,287 shares of the medical device company’s stock after buying an additional 25,007 shares during the quarter. Pinebridge Investments L.P. owned approximately 0.07% of Cooper Companies worth $12,225,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Comerica Securities Inc. lifted its holdings in Cooper Companies by 5.6% in the 4th quarter. Comerica Securities Inc. now owns 903 shares of the medical device company’s stock worth $230,000 after purchasing an additional 48 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Cooper Companies by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 721,796 shares of the medical device company’s stock worth $183,414,000 after acquiring an additional 63,889 shares in the last quarter. Nissay Asset Management Corp Japan ADV raised its holdings in shares of Cooper Companies by 4.4% during the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 4,225 shares of the medical device company’s stock worth $1,251,000 after acquiring an additional 179 shares in the last quarter. OLD National Bancorp IN purchased a new stake in shares of Cooper Companies during the 1st quarter worth approximately $243,000. Finally, First Allied Advisory Services Inc. raised its holdings in shares of Cooper Companies by 27.7% during the 1st quarter. First Allied Advisory Services Inc. now owns 1,174 shares of the medical device company’s stock worth $349,000 after acquiring an additional 255 shares in the last quarter. 96.00% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have recently weighed in on COO. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 target price on the stock in a research report on Friday, June 7th. ValuEngine downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research report on Tuesday. Northcoast Research reissued a “buy” rating and set a $340.00 target price (up previously from $331.00) on shares of Cooper Companies in a research report on Monday, June 3rd. Piper Jaffray Companies set a $360.00 target price on Cooper Companies and gave the company a “buy” rating in a research report on Friday, August 30th. Finally, Raymond James reissued a “buy” rating on shares of Cooper Companies in a research report on Monday, August 26th. One analyst has rated the stock with a sell rating, two have given a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $326.27.
Shares of NYSE COO traded down $4.42 during mid-day trading on Friday, reaching $300.58. 14,346 shares of the company were exchanged, compared to its average volume of 322,884. The company has a quick ratio of 0.73, a current ratio of 1.29 and a debt-to-equity ratio of 0.39. The stock has a market cap of $14.72 billion, a price-to-earnings ratio of 26.43, a P/E/G ratio of 2.24 and a beta of 0.93. Cooper Companies Inc has a 1 year low of $228.65 and a 1 year high of $344.32. The firm has a 50-day moving average of $325.48 and a 200 day moving average of $308.99.
Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, August 29th. The medical device company reported $3.23 earnings per share for the quarter, topping analysts’ consensus estimates of $3.16 by $0.07. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. The firm had revenue of $679.40 million during the quarter, compared to analysts’ expectations of $687.60 million. During the same period in the prior year, the business posted $3.00 EPS. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. On average, equities analysts forecast that Cooper Companies Inc will post 12.32 earnings per share for the current year.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: Risk Tolerance
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.